Gastroenterology clinical trials recruiting in Florida

99 recruiting gastroenterology trials match in Florida. Showing 20.

• A Study of Efimosfermin Alfa in Adults With Hepatic ImpairmentRecruiting

  Phase 1 · GlaxoSmithKline · Tampa, Florida

• Post-sleeve Gastrectomy Gastroesophageal Reflux Disease PredictionRecruiting

  N/A · Mayo Clinic · Rochester, Minnesota

• Acute Exercise and Endogenous Glucose Production in Type 2 Diabetes: Implications for Glycemic Control and Treatment of Hepatic SteatosisRecruiting

  N/A · AdventHealth Translational Research Institute · Orlando, Florida

• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative ColitisRecruiting

  Phase 1 · Ono Pharmaceutical Co., Ltd. · Miami, Florida

• A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 / Phase 3 · Janssen Research & Development, LLC · Cutler Bay, Florida

• A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)Recruiting

  Phase 2 · GlaxoSmithKline · Brandon, Florida

• A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · AbbVie · Orlando, Florida

• A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)Recruiting

  Phase 3 · Takeda · Phoenix, Arizona

• A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Rivus Pharmaceuticals, Inc. · Orlando, Florida

• Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 2 · Abivax S.A. · Brandon, Florida

• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)Recruiting

  Phase 2 · Genentech, Inc. · Kissimmee, Florida

• A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's DiseaseRecruiting

  Phase 2 · Eli Lilly and Company · Miami, Florida

• LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:Recruiting

  Phase 2 · Eli Lilly and Company · Hialeah, Florida

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Recruiting

  Phase 3 · Eli Lilly and Company · Clermont, Florida

• A Pivotal Clinical Study to Investigate the Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)Recruiting

  Phase 3 · GlaxoSmithKline · Miami, Florida

• A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's DiseaseRecruiting

  Phase 3 · Sanofi · Kissimmee, Florida

• A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)Recruiting

  Phase 2 · Boehringer Ingelheim · Miami, Florida

• A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseRecruiting

  Phase 3 · Takeda · Colorado Springs, Colorado

• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting

  Phase 3 · Boehringer Ingelheim · Bradenton, Florida

• Evaluation of Non-Invasive Tests for Metabolic Liver DiseaseRecruiting

  N/A · Foundation for the National Institutes of Health · Miami, Florida

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.